Evidence that testosterone gel does not increase the risk of cardiovascular disease: A Mendelian randomization study of 337,159 European users [0.03%]
睾酮凝胶不会增加心血管疾病风险的证据——欧洲337159例患者 mendel 随机化研究
Xin-Yang He,Zhuo-Nan Jia,Bo-Yu Zhang et al.
Xin-Yang He et al.
Background and objectives: The potential association between testosterone therapy and cardiovascular disease remains a topic of debate. While some studies suggest a link between testosterone treatment and heart disease, d...
Evidence that mycophenolate mofetil is a safe and effective immunosuppressive in the treatment of autoimmune hepatitis and Evans syndrome: Case report [0.03%]
他克莫司治疗自身免疫性肝炎和艾维斯综合征的安全性和有效性的证据：病例报告
Nouha Trad,Asma Mensi,Emna BelHadj Mabrouk et al.
Nouha Trad et al.
Background: Autoimmune hepatitis (AIH) is a chronic immunoinflammatory liver disease frequently associated with extrahepatic autoimmune disorders. Evans syndrome (ES) is a rare chronic autoimmune condition characterized b...
Integrative treatment of the motor neuron disease amyotrophic lateral sclerosis, efficacy of pharmacotherapy, traditional Chinese medicine and importance of respiratory support, life-style, and gastrostomy-assisted nutrition: A review [0.03%]
整合治疗运动神经元病(ALS)的疗效：药物治疗、中医以及呼吸支持、生活方式和胃造口术喂养的重要性：综述论文
Wei Jing,Yutong Shan,Haisheng Wu et al.
Wei Jing et al.
Currently, there are no effective treatments for amyotrophic lateral sclerosis (ALS), a chronic progressive neurodegenerative disease. Although the etiology of ALS is unknown, it is thought that factors such as diet, the environment, and li...
Treatment of polycystic ovary syndrome with QUF7 and mechanism of action: Evidence from network pharmacology analysis that hydroxynaringenin, quercetin, and kaempferol modulate the estrogen receptor gene [0.03%]
基于网络药理学的QUF7治疗多囊卵巢综合征及其作用机制研究：羟芹酚、槲皮素和杜松子酚通过调控雌激素受体基因发挥功效
Yijing He,Weihuan Hu,Fangfang Wang et al.
Yijing He et al.
Objective: This study aims to investigate the clinical effectiveness and underlying pharmacological processes of a patented formulation derived from Chinese herbal medicine (CHM), named Qu's formula 7 (QUF7), in addressin...
Personalized management of acenocoumarol dosage using eGFR: Analysis of INR data in a cohort of 204 patients [0.03%]
基于eGFR的阿塞诺华剂量个性化管理及其对INR影响的队列研究(204例)
Dzhem Farandzha,Vasil Velchev,Dobri Hazarbasanov
Dzhem Farandzha
Background: Acenocoumarol is a widely used vitamin K antagonist, particularly in European countries. While age and body metrics are known to influence dose requirements, the role of renal function in guiding acenocoumarol...
Amyotrophic lateral sclerosis rehabilitation management and non-pharmacological symptomatic treatment: A review [0.03%]
系统性回顾：肌萎缩侧索硬化非药物对症治疗及康复管理研究进展
Yuetong Shan,Wei Jing,Haihan Zhang et al.
Yuetong Shan et al.
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that lacks effective treatment options for the prevention of progression. Relieving swallowing difficulties, reducing breathing difficulties, and alleviating muscle sp...
Barrington G Woodcock-Kloberdanz
Barrington G Woodcock-Kloberdanz
Association of antibiotic treatment for second-trimester GBS with reduced miscarriage risk: Probiotic intervention shows no benefit [0.03%]
第二孕期使用抗生素治疗GBS与流产风险降低相关：益生菌干预无获益
Mei-Ling Guo,Ya-Nuan Chen,Jian-Hong Fang et al.
Mei-Ling Guo et al.
Objective: To investigate the colonization rate of group B Streptococcus (GBS) during the second trimester of pregnancy, the correlation between GBS infection and miscarriage as well as the impact of intervention on pregn...
Analgesia using sufentanil and sufentanil plus dexmedetomidine following cesarean section and effect on placental hypoxia-inducible factors [0.03%]
剖宫产术后使用舒芬太尼及舒芬太尼联合右美托咪定镇痛对胎盘缺氧诱导因子表达的影响
Xiaoling Lv,Xiaoping Lin,Long Ma
Xiaoling Lv
Objective: To investigate the analgesic effect of sufentanil plus dexmedetomidine following cesarean section and to determine its influence on placental hypoxia-inducible factors. ...
Ocrelizumab use before pregnancy and neonatal B-cell depletion: A case report [0.03%]
奥马珠单抗在怀孕前使用及新生儿B细胞耗竭的一例报告
Georgios Eleftheriou,Anna Sangiovanni,Raffaella Butera et al.
Georgios Eleftheriou et al.
Ocrelizumab is a recombinant humanized IgG1 monoclonal antibody that depletes B lymphocytes by binding their surface antigen CD20 and is approved for the relapsing forms of multiple sclerosis (MS). Several studies report that in utero expos...